Cardiovascular risk evaluation: An inexact science

Journal of Hypertension

Volumn 20, Issue 11, 2002, Pages 2127-2130

  Franklin, Stanley S ^a   Wong, Nathan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACCURACY; AGE; AGING; ANTIHYPERTENSIVE THERAPY; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DATA ANALYSIS; DISEASE SEVERITY; DRUG INDICATION; DRUG USE; EDITORIAL; HUMAN; HYPERTENSION; LIFESTYLE; METABOLIC SYNDROME X; METHODOLOGY; OUTCOMES RESEARCH; PATIENT CODING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT INDICATION; TREATMENT PLANNING; HEALTH SURVEY; NOTE; REPRODUCIBILITY;

HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION; REPRODUCIBILITY OF RESULTS;

EID: 0036855884     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200211000-00005     Document Type: Editorial

References (28)

1. Alderman MH. Blood pressure management: Individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119:329-335.
2. Ramsay LE, Wallis EJ, Yeo WW, Jackson PR. Absolute and relative risk in hypertension. In: Bulpitt CJ (editor): Handbook of Hypertension. Epidemiology of Hypertension. Amsterdam: Elsevier Science; 2000. pp. 43-56.
3. Kannel WB, Wilson WF. Hypertension as a cardiovascular risk factor. In: Bulpitt CJ (editor): Handbook of Hypertension. Epidemiology of Hypertension. Amsterdam: Elsevier Science; 2000. pp. 19-42.
4. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
5. Guidelines Subcommittee. 1999 World Health Organization/International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
6. Wallis EJ, Ramsay LE, Haq IU, Ghahramani P, Jackson PR, Rowland-Yeo K, et al. Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish Health Survey population. BMJ 2000; 320:671-676.
7. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R, on behalf of the British Cardiac Society, British Hyperlipidaemia Association. Joint British Hypertension Society and endorsed by the British diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80 (suppl 2):S1-S29.
8. Ministry of Health. Guidelines for the Management of Mildly Raised Blood Pressure in New Zealand. Wellington: Core Services Committee, Ministry of Health; 1995.
9. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensinsive patients according to the JNC VI Risk Stratification. Hypertension 2000; 35:53g-543.
10. Yikona JINM, Wallis EJ, Ramsay LE, and Jackson PR. Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods. J Hypertens 2002; 20:2173-2182.
11. Executive summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
12. Reaven G. Metabolic syndrome. Pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 106:286-288.
13. Anderson KM, Odel PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121:293-298.
14. Vasan RS, Larson MG, Leip MS, Evens JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Finding from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
16. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282:1523-1529.
17. Collins R, Peto R. Antihypertensive drug therapy: Effects on stroke and coronary heart disease. In: Swales JD (editor): Textbook of Hypertension. Oxford: Blackwell Science; 1992. pp. 1156-1164.
18. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. Circulation 1996; 93:697-703.
19. Sagie A. Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329:1912-1917.
20. Van Bortel LMAB, Struijker-Boudier HAJ, Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38:914-921.
21. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27:1214-1218.
22. Simpson FO. Guidelines for antihypertensive therapy: Problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996; 14:683-689.
23. Zanchetti A. Antihypertensive therapy: How to evaluate the benefits. Am J Cardiol 1997; 79:3-8.
24. Begg EJ, Nicholls MG, Richards AM. The management of mildly raised blood pressure in New Zealand: An alternative view. NZ Med J 1996; 109:237-240.
25. Wood D, Backer GD, Faergeman O, Graham I, Manicia G, Pyorala. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998; 16:1407-1414.
26. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The assessment of prognostic risk observational survey. J Hypertens 2002; 20:1307-1314.
27. Chalmers J. Enhancing risk stratification in hypertensive subjects: How far should we go in routine screening for target organ damage? J Hypertens 2002; 20:1255-1257.
28. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.